Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo

Documenti analoghi

• Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo.
  di: Anilkumar C Nirvanappa, et al.
  Pubblicazione: (2016-01-01)
• Correction: Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo
  di: Nirvanappa, Anilkumar C., et al.
  Pubblicazione: (2017)
• Identification of a novel 1,2 oxazine that can induce apoptosis by targeting NF-κB in hepatocellular carcinoma cells
  di: Chaithanya Somu, et al.
  Pubblicazione: (2020-03-01)
• Identification of a novel 1,2 oxazine that can induce apoptosis by targeting NF-κB in hepatocellular carcinoma cells
  di: Somu, Chaithanya, et al.
  Pubblicazione: (2020)
• Novel 1,3,4-Oxadiazole Induces Anticancer Activity by Targeting NF-κB in Hepatocellular Carcinoma Cells
  di: Mohan, Chakrabhavi Dhananjaya, et al.
  Pubblicazione: (2018)